2minutemedicine.com4d
Ticagrelor monotherapy reduces bleeding risk compared to dual antiplatelet therapy for patients following coronary stenting
Ticagrelor was non-inferior to DAPT for the incidence of major adverse cardiovascular and cerebrovascular events. 2.
2minutemedicine.com5d
Adaptimmune’s Afami-cel is the first FDA-approved T-cell receptor therapy for synovial sarcoma
Afami-cel (Tecelra) is the first genetically engineered T-cell receptor therapy for synovial sarcoma Afami-cel demonstrated ...
2minutemedicine.com5d
Amy Boyle
Afami-cel (Tecelra) is the first genetically engineered T-cell receptor therapy for synovial sarcoma Afami-cel demonstrated an overall response rate of... No ads & unlimited access to all current ...
2minutemedicine.com5d
Semaglutide reduces heart failure events in patients with preserved ejection fraction
Patients in the semaglutide group reported fewer heart failure events than those in the placebo group. 2. No significant ...
2minutemedicine.com6d
Tag: congestive heart failure
1. Patients in the semaglutide group reported fewer heart failure events than those in the placebo group. 2. No significant ...